She had only been on the job for a few days, but was already having trouble with career officers at the agency. She was involved in the preparation of the Commissioner and Press Materials for the announcement of Emergency Use Authorization on Covalent Plasma, although it is not clear if this was the reason for its removal.
Her sudden departure comes at a time when the agency, especially during coronavirus, is being tested for handling messages.
CNN has reached out to Miller. In a post he made on his personal Facebook page before Miller’s removal, he wrote that as long as he held the position, he would “work non-stop to accurately deliver information about Covid-19 tests, treatment and vaccine procedures to the public.” As soon as possible. ”
“I will not lie. I will not do anything that violates my personal ethics and values,” the post reads.
Medical experts said Hahn exaggerated the life-saving benefits of the treatment and later Hahn apologized for how he presented the data. He previously said that Mayo Clinic data showed that the use of convulsive plasma reduced the risk of death by 35%, and that if 100 people were found to have coronavirus, 35 would survive treatment.
But this was wrong; This study, which has not yet been peer-reviewed, showed that 8..7% of patients treated within three days of diagnosis died, compared to patients receiving treatment four days or more after their diagnosis – a difference of about 37%. .
People treated with plasma with the highest levels of antibodies had a 35% lower risk of death within one week than those treated with less rich plasma. This study did not show a 35% reduction in overall mortality from plasma use.
Hahn also denied earlier this week that emergency authorization for convulsive plasma was authorized for reasons other than legitimate medical issues, telling CNN that he was “never asked to make a decision on the FDA based on politics.”
“The decisions that FDA scientists are making are based on data,” the commissioner said in a statement.
Miller previously sen. Worked for Ted Cruz, R-Texas and One America News.
The FDA came from White House staff office fees, according to an acquaintance.
The story was updated with additional developments and background information.
The report is contributed by CNN’s Dewan Cole and Jans Jones.
.
